Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.06 USD | -1.36% |
|
-4.32% | -24.05% |
Jul. 01 | Orion, Merck & Co. Convert Agreement into Exclusive Global License to Opevesostat | MT |
Jul. 01 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.05% | 1.24B | |
+20.09% | 67.35B | |
-5.30% | 46.44B | |
+22.19% | 44.28B | |
+36.70% | 29.14B | |
+11.89% | 19.48B | |
+14.26% | 17.17B | |
-25.77% | 15.04B | |
-14.93% | 14.72B | |
-31.27% | 12.07B |
- Stock Market
- Equities
- OEC Stock
- News Orion S.A.
- Orion Set to Acquire 25% Stake in LegoChem Biosciences